Basil Extract (Ocimum basilicum L) Exhibits Antidiabetic and Hepatoprotective Effects via SIRT1 and Peroxisome Proliferator-Activated Receptors (PPARγ) on Gestational Diabetes Mellitus Rats Model
Abstract
Gestational Diabetes Mellitus (GDM) is a disorder of carbohydrate metabolism that causes hyperglycemia and insulin resistance during pregnancy. Sirtuin 1 (SIRT1) and Peroxisome Proliferator-Activated Receptorγ (PPARγ) are genes that play a role in glucose metabolism. Dysregulation of SIRT 1 and PPARγ is associated with the GDM. Hyperglycemia in GDM induces inflammation and oxidative stress in hepatocytes causing liver damage. Basil extract (Ocimum basilicum L) is one of indonesia medicinal plant has been used as traditional medicice in diabetic disorder. This study aims to investigate the hypoglycemic activity of basil extract by evaluating the expression of SIRT 1 and PPARγ in GDM rats and investigate the potential hepatoprotective effect of basil extract by analyzing the rat’s liver histology. Twenty-four of pregnant rats were divided into four groups; negative control, positive group induced by streptozotocin 40 mg/kg BW intraperitoneally, and two groups of GDM rats treated with 100 mg/kg BW and 200 mg/kg BW of basil extract for 14 days. Blood glucose levels were examined with a blood glucose meter. The expression of SIRT 1 and PPARγ was assessed by the RT-PCR. Histological analysis of the rat`s liver was conducted to determine the percentage of cell damage and tissue edem The data were statistically processed using SPSS. The extract of basil at a dose of 200 mg/kg BW showed an anti-diabetic effect which decreased the glucose level concentration by about two times compared to the untreated rat. It enhanced the expression of SIRT-significantly with a value of p= 0.035 (p <0.05). Basil extract-treated group showed a trend of increasing PPARγ expression, but not statistically significant. In addition, HE staining on the liver showed a tendency to improve in the group given basil extract. This Study concluded that basil extract could increase SIRT 1 and potential to be an anti-hyperglycemic therapy with a hepatoprotective effect.
References
2. International Diabetes Federation. IDF Diabetes Atlas 2019 [Internet]. Ninth edit. Suvi Karuranga, Belma Malanda, Pouya Saeedi PS, Contributors, editors. International Diabetes Federation. 2019. 1 p. Available from: http://www.idf.org/about-diabetes/facts-figures
3. Shi GJ, Li Y, Cao QH, Wu HX, Tang XY, Gao XH, et al. In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature. Biomed Pharmacother [Internet]. 2019;109(July 2018):1085–99. Available from: https://doi.org/10.1016/j.biopha.2018.10.130
4. Iskender H, Dokumacioglu E, Sen TM, Ince I, Kanbay Y, Saral S. The effect of hesperidin and quercetin on oxidative stress, NF-κB and SIRT1 levels in a STZ-induced experimental diabetes model. Biomed Pharmacother [Internet]. 2017;90:500–8. Available from: http://dx.doi.org/10.1016/j.biopha.2017.03.102
5. Podolska M, Strycharz J, Szwed M. Hyperglycemia Changes Expression of Key Morphology of Differentiating Human. Nutrients. 2019;11(1835):1–17.
6. Nguyen-Ngo C, Jayabalan N, Salomon C, Lappas M. Molecular pathways disrupted by gestational diabetes mellitus. J Mol Endocrinol. 2019;63(3):R51–72.
7. Luu L, Dai FF, Prentice KJ, Huang X, Hardy AB, Hansen JB, et al. The loss of Sirt1 in mouse pancreatic beta cells impairs insulin secretion by disrupting glucose sensing. Diabetologia. 2013;56(9):2010–20.
8. Lappas M, Andrikopoulos S, Permezel M. Hypoxanthine-xanthine oxidase down-regulates GLUT1 transcription via SIRT1 resulting in decreased glucose uptake in human placenta. J Endocrinol. 2012;213(1):49–57.
9. Gao Y, She R, Sha W. Gestational diabetes mellitus is associated with decreased adipose and placenta peroxisome proliferator-activator receptor γ expression in a Chinese population. Oncotarget. 2017;8(69):113928–37.
10. Agostini M, Schoenmakers E, Mitchell C, Szatmari I, Savage D, Smith A, et al. Non-DNA binding, dominant-negative, human PPARγ mutations cause lipodystrophic insulin resistance. Cell Metab. 2006;4(4):303–11.
11. Olefsky JM. Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists. J Clin Invest. 2000;106(4):467–72.
12. Arshad R, Karim N, Hasan JA. Effects of insulin on placental, fetal and maternal outcomes in gestational diabetes mellitus. Pakistan J Med Sci. 2014;30(2):240–4.
13. Ajmera VH, Gunderson EP, Vanwagner LB, Lewis CE, Carr JJ, Terrault NA. Gestational diabetes mellitus is strongly associated with non-alcoholic fatty liver disease. Am J Gastroenterol [Internet]. 2016;111(5):658–64. Available from: http://dx.doi.org/10.1038/ajg.2016.57
14. Mohamed J, Nazratun Nafizah AH, Zariyantey AH, Budin SB. Mechanisms of diabetes-induced liver damage: The role of oxidative stress and inflammation. Sultan Qaboos Univ Med J. 2016;16(2):e132–41.
15. Chaudhary S, Semwal A, Kumar H, Chandra H. ScienceDirect In-vivo study for anti-hyperglycemic potential of aqueous extract of Basil seeds ( Ocimum basilicum Linn ) and its in fl uence on biochemical parameters , serum electrolytes and haematological indices. Biomed Pharmacother [Internet]. 2016; Available from: http://dx.doi.org/10.1016/j.biopha.2016.11.020
16. Zhan Y, An X, Wang S, Sun M, Zhou H. Basil polysaccharides: A review on extraction, bioactivities and pharmacological applications. Bioorganic Med Chem [Internet]. 2020;28(1):115179. Available from: https://doi.org/10.1016/j.bmc.2019.115179
17. Ezeani C, Ezenyi I, Okoye T, Okoli C. Ocimum basilicum extract exhibits antidiabetic effects via inhibition of hepatic glucose mobilization and carbohydrate metabolizing enzymes. J Intercult Ethnopharmacol. 2017;6(1):22–8.
18. Güez CM, de Souza RO, Fischer P, Leão MF de M, Duarte JA, Boligon AA, et al. Evaluation of basil extract (Ocimum basilicum L.) on oxidative, anti-genotoxic and anti-inflammatory effects in human leukocytes cell cultures exposed to challenging agents. Brazilian J Pharm Sci. 2017;53(1).
19. Khair-ul-Bariyah S, Ahmed D, Ikram M. Ocimum Basilicum: A Review on Phytochemical and Pharmacological Studies. Pakistan J Chem. 2012;2(2):78–85.
20. Medina-Gomez G, Virtue S, Lelliott C, Boiani R, Campbell M, Christodoulides C, et al. The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-γ2 isoform. Diabetes. 2005;54(6):1706–16.
21. Wu A, Ying Z, Gomez-Pinilla F. Oxidative stress modulates Sir2α in rat hippocampus and cerebral cortex. Eur J Neurosci. 2006;23(10):2573–80.
22. Lappas M, Hiden U, Desoye G, Froehlich J, Mouzon SH De, Jawerbaum A. The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxidants Redox Signal. 2011;15(12):3061–100.
23. Hu T, Shi JJ, Fang J, Wang Q, Chen YB, Zhang SJ. Quercetin ameliorates diabetic encephalopathy through SIRT1/ER stress pathway in db/db mice. Aging (Albany NY). 2020;12(8):7015–29.
24. Hosni AA, Abdel-Moneim AA, Abdel-Reheim ES, Mohamed SM, Helmy H. Cinnamaldehyde potentially attenuates gestational hyperglycemia in rats through modulation of PPARγ, proinflammatory cytokines and oxidative stress. Biomed Pharmacother [Internet]. 2017;88:52–60. Available from: http://dx.doi.org/10.1016/j.biopha.2017.01.054
25. Wu Y, Xia Z, Zhao BO, Leng YAN, Dou J, Meng Q, et al. injury induced by ischemia / reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions. 2017;2017:389–99.
26. Damasceno DC, Netto AO, Iessi IL, Gallego FQ, Corvino SB, Dallaqua B, et al. Streptozotocin-induced diabetes models: Pathophysiological mechanisms and fetal outcomes. Biomed Res Int. 2014;2014.